1. Ramezaniaghdam M, Nahdi ND, Reski R. Recombinant spider silk: promises and bottlenecks. Front Bioeng Biotechnol. 2022;10:1–18.
2. Molfetta M, Morais EG, Barreira L, Bruno GL, Porcelli F, Dugat-Bony E, et al.
Protein sources alternative to meat: state of the art and involvement of
fermentation. Foods. 2022;11:1–30.
3. Aro N, Ercili-Cura D, Andberg M, Silventoinen P, Lille M, Hosia W, et al.
Production of bovine beta-lactoglobulin and hen egg ovalbumin by
Trichoderma reesei using precision fermentation technology and testing
of their techno-functional properties. Food Res Int. 2023;163:112131.
4. Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies.
2020;9:34.
5. Di Nardo F, Chiarello M, Cavalera S, Baggiani C, Anfossi L. Ten years of
lateral flow immunoassay technique applications: trends, challenges and
future perspectives. Sensors. 2021. https://doi.org/10.3390/s21155185.
6. Traenkle B, Rothbauer U. Under the microscope: single-domain antibodies for live-cell imaging and super-resolution microscopy. Front Immunol.
2017;8:1–8.
7. Gomes AR, Byregowda SM, Veeregowda BM, Balamurugan V. An overview
of heterologous expression host systems for the production of recombinant proteins. Adv Anim Vet Sci. 2016;4:346–56.
8. Whittall DR, Baker KV, Breitling R, Takano E. Host systems for the production of recombinant spider silk. Trends Biotechnol. 2021;39:560–73.
9. Frenzel A, Hust M, Schirrmann T. Expression of recombinant antibodies.
Front Immunol. 2013;4:1–20.
10. Nagorsen D, Kufer P, Baeuerle PA, Bargou R. Blinatumomab: a historical
perspective. Pharmacol Ther. 2012;136:334–42.
11. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of
single domains. Nat Biotechnol. 2005;23:1126–36.
12. Arbabi-Ghahroudi M. Camelid single-domain antibodies: historical
perspective and future outlook. Front Immunol. 2017;8:1–8.
13. de Marco A. Biotechnological applications of recombinant single-domain
antibody fragments. Microb Cell Fact. 2011;10:44.
14. Saerens D, Ghassabeh GH, Muyldermans S. Single-domain antibodies as building blocks for novel therapeutics. Curr Opin Pharmacol.
2008;8:600–8.
15. Muyldermans S, Nanobodies. Natural single-domain antibodies. Annu
Rev Biochem. 2013;82:775–97.
16. Harmsen MM, De Haard HJ. Properties, production, and applications of
camelid single-domain antibody fragments. Appl Microbiol Biotechnol.
2007;77:13–22.
17. de Marco A. Recombinant expression of nanobodies and nanobodyderived immunoreagents. Protein Expr Purif. 2020;172:105645.
18. Demain AL, Vaishnav P. Production of recombinant proteins by microbes
and higher organisms. Biotechnol Adv. 2009;27:297–306.
19. Nevalainen H, Peterson R. Heterologous Expression of proteins in
Trichoderma. Biotechnol Biol Trichoderma. 2014. https://doi.org/10.1016/
B978-0-444-59576-8.00007-2.
20. Cherry JR, Fidantsef AL. Directed evolution of industrial enzymes: an
update. Curr Opin Biotechnol. 2003;14:438–43.
21. Fonseca LM, Parreiras LS, Murakami MT. Rational engineering of the
Trichoderma reesei RUT-C30 strain into an industrially relevant platform
for cellulase production. Biotechnol Biofuels. 2020;13:1–15.
22. Noguchi T, Saito H, Nishiyama R, Yoshida N, Matsubayashi T, Teshima Y,
et al. Isolation of a cellulase hyperproducing mutant strain of Trichoderma reesei. Bioresour Technol Reports. 2021;15:100733.
23. Rantasalo A, Vitikainen M, Paasikallio T, Jäntti J, Landowski CP, Mojzita D.
Novel genetic tools that enable highly pure protein production in Trichoderma reesei. Sci Rep. 2019;9:1–12.
24. Zhang J, Wu C, Wang W, Wang W, Wei D. A versatile Trichoderma reesei
expression system for the production of heterologous proteins. Biotechnol Lett. 2018;40:965–72.
Arai et al. Microbial Cell Factories
(2023) 22:103
25. Chai S, Zhu Z, Tian E, Xiao M, Wang Y, Zou G, et al. Building a versatile
protein production platform using engineered Trichoderma reesei. ACS
Synth Biol. 2022;11:486–96.
26. Mandels M, Reese ET. Induction of cellulase in fungi by cellobiose. J
Bacteriol. 1960;79:816–26.
27. Pakula TM, Nygren H, Barth D, Heinonen M, Castillo S, Penttilä M, et al.
Genome wide analysis of protein production load in Trichoderma reesei.
Biotechnol Biofuels BioMed Central. 2016;9:1–26.
28. Zhang Y-HP, Lynd LR. A functionally based model for hydrolysis of cellulose by fungal cellulase. Biotechnol Bioeng. 2006;94:888–98.
29. Zhang X, Li X, Xia L. Heterologous expression of an alkali and thermotolerant lipase from Talaromyces thermophilus in Trichoderma reesei. Appl
Biochem Biotechnol. 2015;176:1722–35.
30. Ma L, Zhang J, Zou G, Wang C, Zhou Z. Improvement of cellulase
activity in Trichoderma reesei by heterologous expression of a betaglucosidase gene from penicillium decumbens. Enzyme Microb Technol.
2011;49:366–71.
31. Seiboth B, Hakola S, Mach RL, Suominen PL, Kubicek CP. Role of four
major cellulases in triggering of cellulase gene expression by cellulose in
Trichoderma reesei. J Bacteriol. 1997;179:5318–20.
32. Ren M, Wang Y, Liu G, Zuo B, Zhang Y, Wang Y, et al. The effects of deletion
of cellobiohydrolase genes on carbon source-dependent growth and
enzymatic lignocellulose hydrolysis in Trichoderma reesei. J Microbiol.
2020;58:687–95.
33. Adnan M, Zheng W, Islam W, Arif M, Abubakar YS, Wang Z, et al. Carbon
catabolite repression in filamentous fungi. Int J Mol Sci. 2018;19:1–23.
34. Arai T, Ichinose S, Shibata N, Kakeshita H, Kodama H, Igarashi K, et al.
Inducer-free cellulase production system based on the constitutive
expression of mutated XYR1 and ACE3 in the industrial fungus Trichoderma reesei. Sci Rep. 2022;12:1–14.
35. Nakazawa H, Kawai T, Ida N, Shida Y, Shioya K, Kobayashi Y, et al. A high performance Trichoderma reesei strain that reveals the importance of xylanase
III in cellulosic biomass conversion. Enzyme Microb Technol. 2016;82:89–95.
36. Landowski CP, Huuskonen A, Wahl R, Westerholm-Parvinen A, Kanerva A,
Hänninen AL, et al. Enabling low cost biopharmaceuticals: a systematic
approach to delete proteases from a well-known protein production host
trichoderma reesei. PLoS ONE. 2015;10:1–28.
37. Häkkinen M, Arvas M, Oja M, Aro N, Penttilä M, Saloheimo M, et al. Reannotation of the CAZy genes of Trichoderma reesei and transcription in
the presence of lignocellulosic substrates. Microb Cell Fact. 2012;11:1–26.
38. Koide A, Tereshko V, Uysal S, Margalef K, Kossiakoff AA, Koide S. Exploring
the capacity of minimalist protein interfaces: interface energetics and
affinity maturation to picomolar KD of a single- domain antibody with a
flat paratope. J Mol Biol. 2007;373:941–53.
39. Rouet R, Dudgeon K, Christie M, Langley D, Christ D. Fully human VH
single domains that rival the stability and cleft recognition of camelid
antibodies. J Biol Chem. 2015;290:11905–17.
40. Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, et al.
Caplacizumab for acquired thrombotic thrombocytopenic purpura. N
Engl J Med. 2016;374:511–22.
41. European Medicines. Agency (EMA). Cablivi: assessment report. 2018.
https://www.ema.europa.eu/en/documents/assessment-report/cablivi-
epar-public-assessment-report_en.pdf
42. Ishiwatari-Ogata C, Kyuuma M, Ogata H, Yamakawa M, Iwata K, Ochi M,
et al. Ozoralizumab, a humanized anti-TNFα N
ANOBODY® compound,
exhibits efficacy not only at the onset of arthritis in a human TNF Transgenic mouse but also during secondary failure of administration of an
anti-TNFα IgG. Front Immunol. 2022;113:8008.
43. Meng F, Wei D, Wang W. Heterologous protein expression in Trichoderma
reesei using the cbhII promoter. Plasmid. 2013;70:272–6.
44. Paloheimo M, Mäntylä A, Kallio J, Suominen P. High-yield production of a
bacterial xylanase in the filamentous fungus Trichoderma reesei requires
a carrier polypeptide with an intact domain structure. Appl Environ
Microbiol. 2003;69:7073–82.
45. Landowski CP, Mustalahti E, Wahl R, Croute L, Sivasiddarthan D, Parvinen
AW, et al. Enabling low cost biopharmaceuticals: high level interferon alpha – 2b production in Trichoderma reesei. Microb Cell Fact.
2016;15:1–15.
46. Kumaraswamy S, Tobias R. Label-free kinetic analysis of an antibody-antigen interaction using biolayer interferometry. Methods Mol Biol. 2015.
https://doi.org/10.1007/978-1-4939-2425-7_10.
Page 16 of 16
47. Aggarwals BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, et al.
Human tumor necrosis factor. production, purification, and characterization. J Biol Chem. 1985;260:2345–54.
48. Schirrmann T, Al-halabi L, Dübel S, Hust M. Production systems for recombinant antibodies. Front Biosci. 2008. https://doi.org/10.2741/3024.
49. Nyyssönen E, Penttilä M, Harkki A, Saloheimo A, Knowles JKC, Keränen S.
Efficient production of antibody fragments by the filamentous fungus
Trichoderma reesei. Nat Biotechnol. 1993;11:591–5.
50. Zhang J, Li J, Gao L, Waghmare PR, Qu J, Liu G. Expression of a SARSCoV-2 neutralizing nanobody in Trichoderma reesei. Chin J Biotechnol.
2022;38:2250–8.
51. Coller SP, Schoisswohl D, Baron M, Parriche M, Kubicek CP. Role of
endoproteolytic dibasic proprotein processing in maturation of secretory
proteins in Trichoderma reesei. Appl Environ Microbiol. 1998;64:3202–8.
52. Fonseca LM, Parreiras LS, Murakami MT. Rational engineering of the
Trichoderma reesei RUT-C30 strain into an industrially relevant platform
for cellulase production. Biotechnol Biofuels. 2020;13:93.
53. Derntl C, Gudynaite-Savitch L, Calixte S, White T, Mach RL, Mach-Aigner
AR. Mutation of the Xylanase regulator 1 causes a glucose blind hydrolase expressing phenotype in industrially used Trichoderma strains.
Biotechnol Biofuels. 2013;6:62.
54. Ellilä S, Fonseca L, Uchima C, Cota J, Goldman GH, Saloheimo M, Sacon
V, Siika-Aho M. Development of a low-cost cellulase production process
using Trichoderma reesei for brazilian biorefineries. Biotechnol Biofuels.
2017;10:30.
55. Zhang J, Chen Y, Wu C, Liu P, Wang W, Wei D. The transcription factor ACE3 controls cellulase activities and lactose metabolism via two
additional regulators in the fungus Trichoderma reesei. J Biol Chem.
2019;294:18435–50.
56. de Lima EA, Mandelli F, Kolling D, Matsusato Souza J, de Oliveira Filho CA,
Ribeiro da Silva M, et al. Development of an economically competitive
Trichoderma-based platform for enzyme production: bioprocess optimization, pilot plant scale-up, techno-economic analysis and life cycle
assessment. Bioresour Technol. 2022;364:128019.
57. Novy V, Nielsen F, Seiboth B, Nidetzky B. The influence of feedstock
characteristics on enzyme production in Trichoderma reesei: a review on
productivity, gene regulation and secretion profiles. Biotechnol Biofuels.
2019;12:238.
58. Humbird D, Davis R, Tao L, Kinchin C, Hsu D, Aden A, Schoen P, Lukas J,
Olthof B, Worley M, Sexton D, Dudgeon D. Process design and economics
for biochemical conversion of lignocellulosic biomass to ethanol. Volume
NREL/TP-5100-47764. NREL; 2011. http://www.nrel.gov/docs/fy11osti/
47764.pdf.
59. Kawamori M, Morikawa Y, Takasawa S. Induction and production of
cellulases by L-sorbose in Trichoderma reesei. Appl Microbiol Biotechnol
Microbiol Biotechnol. 1986;24:449–53.
60. Penttilä M, Nevalainen H, Rättö M, Salminen E, Knowles J. A versatile
transformation system for the cellulolytic filamentous fungus Trichoderma reesei. Gene. 1987;61:155–64.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ready to submit your research ? Choose BMC and benefit from:
• fast, convenient online submission
• thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
• gold Open Access which fosters wider collaboration and increased citations
• maximum visibility for your research: over 100M website views per year
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
...
論文の公開元へ
